source
- MiniMed appoints diabetes and digital health veteran David Segal as chief medical officerMiniMed, the insulin pump maker that spun off from Medtronic, announced the appointment of Dr. David Segal as its new chief medical officer. Segal replaces Dr. Robert Vigersky, who has served as C…
- AbbVie bets up to $1.47B for Nxera’s discarded IBD programAbbVie’s $100 million upfront cash payment will purchase global rights to Nxera’s deprioritized oral small molecule, which has already completed Phase 1 testing.BioSpace · 5d ago↗ source
- Pfizer raises 2026 outlook as oncology and migraine growth balances Covid product decline